Table 3

Expression of markers, gender and their prediction for disease-specific survival in patients with soft tissue sarcomas (univariate analysis; log-rank test), All = 193, Males = 81, Females = 112
Marker expression Patients (n) Patients (%) Median survival (months) 5-year survival (%) P
Skp2, all
Low 109 56 NR 63 0.050
High 67 45 59 50
Missing 17 9
Skp2, men
Low 50 62 NR 63 0.577
High 23 28 67 61
Missing 8 10
Skp2, women
Low 59 53 NR 63 0.066
High 44 39 49 44
Missing 9 8
ER, all
Low 112 58 123 57 0.725
High 72 67 91 57
Missing 9 5
ER, men
Low 49 60 NR 69 0.089
High 29 36 58 49
Missing 3 4
ER, women
Low 63 56 57 47 0.041
High 43 38 NR 62
Missing 6 5
PGR, all
Low 132 68 NR 62 0.101
High 57 30 52 46
Missing 4 2
PGR, men
Low 64 79 NR 69 0.010
High 15 19 41 33
Missing 2 2
PGR, women
Low 68 61 80 55 0.832
High 42 38 74 51
Missing 2 2

Abbreviations: NR, not reached.

Sorbye et al.

Sorbye et al. BMC Clinical Pathology 2013 13:9   doi:10.1186/1472-6890-13-9

Open Data